Skip to main content
. 2023 Oct 9;18(10):e0292591. doi: 10.1371/journal.pone.0292591

Fig 2. Three-year overall survival in subgroup with NLR and ALC at pre-CCRT and NLR and ALC change.

Fig 2

(a) High and low NLR at pre-CCRT, (b) end-CCRT ΔNLR, and (d) end-AC ΔNLR. NLR, neutrophil to lymphocyte ratio; CCRT, concurrent chemoradiotherapy; AC, adjuvant chemotherapy.